2017 World Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Publisher Name :
Date: 20-Mar-2017
No. of pages: 1200
Price : Single User: US $ 34750  US $ 27800 Corporate User: US $ 75900  US $ 60720
This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100.

VPGMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Worldwide Market Overview

- Estimated universe of laboratories performing cancer diagnostic testing by country.

- Five-year test volume and sales projections by country.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Cancer Diagnostic Tests—Over 200 current and emerging assays including:

ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Geographic Coverage

- France

- Germany

- Italy

- Japan

- Spain

- UK

- US

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual cancer diagnostic test and country.

- Five-year test volume and sales forecasts for major cancer diagnostic tests by country and market segment, including:

- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Cancer Clinics

- Ambulatory Care Centers

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

- Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.

Current and Emerging Products

- Review of over 200 current and emerging cancer diagnostic tests, including:

- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.

- Instrumentation review analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operatingcharacteristics, features and selling prices.

Technology Assessment

- Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments ofmajor suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

Contains 1,200 pages and 450 tables

This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

2017 World Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Table of Contents
N/A
  • EMEA Prostate Cancer Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 119
    "The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and......
  • Cancer Diagnostics Market 2021: Supplier Shares and Segment Sales Forecasts by Country, Competitive Profiles, Emerging Markers, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 7500 Onwards        Pages: 0
    This new report from VPGMarketResearch.com provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents:Estimated numbers of cancer testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.Marketing and technological assessment, as well as medical rati......
  • Tumor Markers and Special Chemistry Market 2021: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 320-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts b......
  • Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2017
    Published: 10-Nov-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Checkpoint Inhibitors for Treating Cancer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Checkpoint Inhibitors for Treating Cancer in these regions, from 2012 to 2022 (forecast), covering - North......
  • Global and Regional HPV Testing Market Research Report 2017
    Published: 08-Nov-2017        Price: US 3500 Onwards        Pages: 134
    Summary The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle Ea......
  • Global Cancer Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts
    Published: 01-Nov-2017        Price: US 2995 Onwards        Pages: 700
    "Delivery of this report will take 1-3 days after purchase." The Global Cancer Diagnostics Partnering 2010-2017 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract doc......
  • Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023
    Published: 25-Oct-2017        Price: US 4200 Onwards        Pages: 75
    The 2017 study has 75 pages, 28 tables and figures. Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and lowering care delivery costs. Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments i......
  • Global and Regional Checkpoint Inhibitors for Treating Cancer Market Research Report 2017
    Published: 24-Oct-2017        Price: US 3500 Onwards        Pages: 126
    Summary Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-......
  • Cancer Diagnostics 2021: Supplier Shares and Market Segmnet Forecasts by Tests--A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Competitive Intelligence
    Published: 23-Oct-2017        Price: US 24500 Onwards        Pages: 1200
    Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the nextfive years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs